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Heart developmentth from the endocardium and epicardium regulate appropriate growth of the
myocardium during cardiac development. Epicardially-derived cells play also a key role in development of
the coronary vasculature. This process involves transformation of epithelial (epicardial) cells to mesenchymal
cells (EMT). Similarly, a subset of endocardial cells undergoes EMT to form the mesenchyme of endocardial
cushions, which function as primordia for developing valves and septa. While it has been suggested that
transforming growth factor-βs (Tgf-β) play an important role in induction of EMT in the avian epi- and
endocardium, the function of Tgf-βs in corresponding mammalian tissues is still poorly understood. In this
study, we have ablated the Tgf-β type I receptor Alk5 in endo-, myo- and epicardial lineages using the Tie2-
Cre, Nkx2.5-Cre, and Gata5-Cre driver lines, respectively. We show that while Alk5-mediated signaling does
not play a major role in the myocardium during mouse cardiac development, it is critically important in the
endocardium for induction of EMT both in vitro and in vivo. Moreover, loss of epicardial Alk5-mediated
signaling leads to disruption of cell–cell interactions between the epicardium and myocardium resulting in a
thinned myocardium. Furthermore, epicardial cells lacking Alk5 fail to undergo Tgf-β-induced EMT in vitro.
Late term mutant embryos lacking epicardial Alk5 display defective formation of a smooth muscle cell layer
around coronary arteries, and aberrant formation of capillary vessels in the myocardium suggesting that Alk5
is controlling vascular homeostasis during cardiogenesis. To conclude, Tgf-β signaling via Alk5 is not required
in myocardial cells during mammalian cardiac development, but plays an irreplaceable cell-autonomous role
regulating cellular communication, differentiation and proliferation in endocardial and epicardial cells.
© 2008 Elsevier Inc. All rights reserved.IntroductionThe heart is the ﬁrst functional organ to develop in vertebrates.
During gastrulation, cardiogenic mesodermal cells form the so called
cardiogenic ﬁeld, which subsequently gives rise to a linear heart tube
composed of outer myocardial and inner endothelial layers (Anderson
et al., 2003). After cardiac looping, cardiac neural crest cells migrate to
the base of the aortic sac and form the aortico-pulmonary septum,
which gradually separates the aorta from the pulmonary trunk
(Hutson and Kirby, 2003). At the same time (around embryonic days
9.0–9.5 [E9.0–E9.5]), a region between the developing atria and
ventricles is speciﬁed to form an atrio-ventricular canal (AVC), an
important structure making up the heart-valve inducing ﬁeld
(Eisenberg and Markwald, 1995). First the extracellular matrix rich
in hyaluronic acid is deposited by the AVC myocardium followed by
epithelial-to-mesenchymal transformation (EMT) of a subset of
endocardial cells. The formed endocardial cushions will be further
reﬁned to form the AV valves and septa.l rights reserved.Soon after cardiac looping, a separate cell population derived from
the hepatic primordium gives rise to the proepicardial cells near a
venous pole of the developing heart (Bernanke and Velkey, 2002).
Epicardial progenitor cells then dislodge as cellular vesicles, which
spread out, and gradually cover the entire developing heart to form a
coherent epicardium. A subpopulation of epicardial cells undergoes
EMT and migrates into the subepicardial space rich in extracellular
matrix proteins. It has been suggested that these transformed
mesenchymal cells will produce cardiac ﬁbroblasts and the vascular
smooth muscle of the adult heart (Reese et al., 2002; Wada et al.,
2003). Formation of coronary vasculature is essential once the
myocardium becomes so thick that diffusion is not able to supply
enough nutrients and oxygen to the heart.
A crucial function of Tgf-beta ligands during murine heart
development was ﬁrst suggested by the conventional knockout mice
studies (Sanford et al., 1997). While Tgfb1−/− and Tgfb3−/−mice show no
obvious signs of congenital heart defects (Kaartinen et al., 1995;
Proetzel et al., 1995; Shull et al., 1992), Tgfb2−/− embryos display
multiple cardiac defects(Sanford et al., 1997). These include the
double-outlet right ventricle (DORV), which is known to derive from
an error in development of the second heart ﬁeld that contributes to
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display a defective myocardialization that is associated with a
deregulation of neural crest cell apoptosis (Bartram et al., 2001).
Tgf-β signaling, which is predominantly mediated via a heterote-
trameric receptor complex composed of two Tgf-β type II (TgfβRII) and
two type I (Alk5) receptors, has also been implicated in inductionof both
endocardial and epicardial EMT (Brown et al., 1996; Jiao et al., 2006).
Experiments on chick proepicardial organ and epicardial explant
cultures have suggested that Tgf-β signaling via Alk5 is required for
the lossof epithelial cell character of epicardial cells,while another type I
receptor Alk2, known to mediate mainly Bmp signals, was shown to
stimulate earlier proepicardial (PE) activation events (Compton et al.,
2006; Olivey et al., 2006). Moreover, a recent study demonstrated that
Tgf-β type III receptor (β-glycan), which binds Tgf-β2 with high afﬁnity,
is required for appropriate coronary vessel development in mouse
embryos (Compton et al., 2007). Yet, the role of Tgf-βs in epicardial EMT,
even in avians, is still controversial, since other studies have suggested
that Fgfs are responsible of inducing epicardial EMT, while Tgf-βs would
restrain their function (Morabito et al., 2001).
The Tgf-β type I receptor Alk5 was also recently shown to mediate
endocardial transformation in the chick (Mercado-Pimentel et al., 2007).
Interestingly, the murine Tgf-β type II receptor (TgfβRII, a prototypical
binding partner of Alk5) was shown to be required for EMT in vitro, but
not in vivo (Jiao et al., 2006). This discrepancy suggests that there is a
mechanistic difference inTgf-β signalingbetween avianandmurineAVC
transformation. Alternatively, it is possible that Alk5 can also interact
with other members of the type II receptor family as recently suggested
(Dudas et al., 2006). Other studies have demonstrated that Bmp2 is
required both for speciﬁcation of the AV canal myocardium and for
endocardial EMT (Ma et al., 2005; Rivera-Feliciano and Tabin, 2006).
However, it is currently not clear whether Bmp2-induced EMT in the
AVC is mediated via Alk2 or Alk3, or whether they are both
synergistically involved, since endothelial-speciﬁc abrogation of either
Alk2 or Alk3 leads to a failure in EMT and severe defects in endocardial
cushions in vitro and in vivo (Ma et al., 2005; Park et al., 2006; Song et al.,
2007; Wang et al., 2005). Interestingly, deletion of Alk2 in endothelial
cells not only attenuates phosphorylation of Bmp Smads 1/5/8, but also
affects the activation of Tgf-beta Smads 2/3 (Wang et al., 2005). Based on
these studies, it is likely that Smad2/3 activation, and thus Alk5 signaling
is also important for endocardial EMT in mammals.
In the present study we have analyzed the role of Alk5 during
mouse heart development in vivo. Speciﬁcally, we deleted Alk5 in the
endocardium, myocardium and in epicardium by using the Tie2-Cre,
Nkx2.5-Cre and Gata5-Cre transgenic driver lines, respectively (Koni
et al., 2001; Merki et al., 2005; Moses et al., 2001). We discovered that
while Alk5 is redundant in cardiomyocyte development, it is needed
in the endocardium for appropriate EMT both in vitro and in vivo, and
for the subsequent endocardial cushion development. We show that
in the epicardium Alk5 is required for epicardial to mesenchymal
transformation in vitro, and for normal epicardial attachment and
function in vivo. Moreover, our data indicate that disturbances in
epicardial Alk5-mediated signaling lead to attenuated myocardial
growth, defective formation of a smoothmuscle cell layer surrounding
coronary vessels and dramatic increase in a number of capillary
vessels in the myocardium during late cardiac development.
Materials and methods
Mice, genotyping, timed-matings and embryo isolation
All mice were maintained on mixed genetic backgrounds, and all
studies were carried out at the Animal Care Facility of the Saban
Research Institute in accordance with national and institutional guide-
lines. To generate endothelial-speciﬁc Alk5mutants, Alk5FX/FXmicewere
crossed with Tie2-Cre driver mice (Koni et al., 2001), which were also
heterozygous for the Alk5KO allele. The resulting compound hetero-zygotes for the Alk5FX and Alk5KO alleles, which also carry the Cre
transgene (Alk5FX/KO/Tie2-Cre+/WT), have Alk5 speciﬁcally inactivated in
endothelial cells (herein termed Alk5/Tie2-Cre), while the littermates
with incomplete combinations (Alk5FX/KO/Tie2-CreWT/WT, Alk5FX/WT/Tie2-
CreWT/WT and Alk5FX/WT/Tie2-Cre+/WT) of these alleles (which were all
phenotypically indistinguishable from wild-type embryos) serve as
controls. A similar breeding strategy was used to generate mouse
mutants lacking Alk5 in themyocardium (Alk5/Nkx2.5-Cre) (Moses et al.,
2001) and the epicardium (Alk5/Gata5-Cre) (Merki et al., 2005).
Oligonucleotides for PCR-genotyping of the Alk5FX and for Alk5KO alleles
as well as for Cre have been described elsewhere (Dudas et al., 2006).
Tie2-Cre and Rosa26-reporter (R26R) mice were obtained from the
Jackson Laboratory (Bar Harbor, ME, USA); for detailed PCR-genotyping,
see http://www.jax.org. Nkx2.5-Cre and Gata5-Cre mice have been
previously described (Merki et al., 2005; Moses et al., 2001).
Histological analyses, R26 reporter assay and immunostaining
For histology, embryos were ﬁxed with 4% formaldehyde for 2–14 h,
dehydrated and embedded in parafﬁn wax. Sections (7–8 μm) were
stainedwithHematoxylin andEosin. Embryos and sectionswere stained
for β-galactosidase activity as described (Hogan et al., 1994). For
immunohistochemistry, ﬁxed sections were stained with antibodies
forWT1 (SantaCruzBiotech.),N-cadherin (Invitrogen), ZO1 (Invitrogen),
vascular smooth muscle myosin heavy chain (Biomedical Technologies
Inc.) and Claudin-5 (Invitrogen). For VE-cadherin, β-galactosidase and
PECAM-1 immunostaining, tissueswere processed for frozen sectioning
followed by staining with corresponding antibodies (antibodies for VE-
cadherin, β-galactosidase and PECAM-1 were from BD Pharmingen, MP
Biochemicals and BD Pharmingen, respectively).
Apoptosis and cell proliferation
Apoptotic cells were detected in parafﬁn sections as a green
ﬂuorescence using DeadEnd Fluorometric TUNEL system (Promega).
Cell proliferationwas immunodetected using BrdU incorporation assay
(Amersham). Brieﬂy, pregnant females were injected intraperitoneally
with 200 μl of Amersham BrdU labeling reagent. After 40 min, the
female mice were euthanized with CO2, embryos were harvested, and
processed for BrdU immunostaining according to the manufacturer's
instructions. BrdU-positive cells were detected with Alexa Fluor 488-
conjugated (green) secondary antibodies. Slides were counterstained
with Propidium Iodide. For BrdU/MF20 double labeling, cells were ﬁrst
stained for BrdU as outlined above followed by labeling for sarcomeric
myosin heavy chain using mouse monoclonal MF20 primary antibody
followed by Alexa Fluor 594-conjugated anti-mouse IgG2b secondary
antibody (Invitrogen) (Redﬁeld et al.,1997). Slideswere counterstained
with DAPI. Positively stained cells were counted manually in deﬁned
areas of tissues. Statistical analysis of cell counts in serial sections and
comparison of mutant specimenswith controls was performed using a
nonparametric Wilcoxon Rank Sum Test.
Epicardial and AVC canal explant cultures
Epicardial cultures were established as described (Chen et al., 2002).
Somemutant and control cultureswere treatedwith 10 ng/ml of human
recombinant hrTgf-β3 (Sigma Chemical Co., St Louis, MO) for 24 h. Both
treated and untreated cultures were ﬁxed with 2% formaldehyde for
15min, and stainedwith anti-ZO1antibody (Invitrogen) for thepresence
of the tight junction protein, zonula occludens and with FITC-phalloidin
(Sigma Chemical Co.) for the presence of ﬁlamentous actin (f-actin). For
AVC explant cultures, collagen gels (1mg/ml, type I rat tail collagen from
BD) were prepared in OptiMEM supplemented with 1% fetal calf serum,
1xITS (insulin, transferrin and selenium) and penicillin/streptomysin
(1×) all from Invitrogen (Sugi et al., 2004). AV regions of the hearts were
dissected from E10 embryos, cut longitudinally to expose the lumen and
210 S. Sridurongrit et al. / Developmental Biology 322 (2008) 208–218placed on the collagen gels. Additional media was added to the cultures
2 h later and incubation was continued under standard tissue culture
conditions (37 °C, 100% humidity, 8% CO2).
RT-PCR and real-time PCR analyses
RNAs from ventricles were extracted using the RNeasy mini kit
(Qiagen). Omniscript RT (Qiagen) was used to generate cDNA from
1 μg of RNA. The PCR reactions were performed using platinum Tag











Real-time PCRwas carried out with a ABI 7500 Real Time PCR system
using the Applied Biosystems Taqman UniversalMastermix (Roche) and
universal probe/primer sets for the Fgf9 gene [mouse universal probe#60
(Roche). Left primer 5′TGCAGGACTGGATTTCATTTAG3′, and right primer 5′
CCAGGCCCACTGCTATACTG3′]. Relative quantiﬁcation of gene expression
between samples was performed using the ABI 7500 Software v2.0.
Results
Tgf-β signaling via Alk5 is required in endothelial but not in myocardial
cells for appropriate cardiac development
To analyze the role of Alk5 in endothelial and myocardial cells in
vivo, we deleted the Alk5 gene in these cell types by crossing miceFig. 1. Deletion of Alk5 in endothelial and myocardial cells. (A) The ﬂoxed Alk5 gene is efﬁc
sequences in exons 2 and 4 (blue arrowheads) demonstrates that the ﬂoxed exon 3 (yellow)
displays an expected 399-bp fragment. (B) Alk5/Tie2-Cre mutants display severe cranial and
Moreover, some Alk5/Tie2-Cre mutants demonstrate severe cardiac edema (right, white arr
Deletion of Alk5 in myocardial cells using the Nkx2.5-Cre driver line does not reveal any ma
levels have been shown from rostral (top row) to caudal (bottom row). LV, right ventricle; Rcarrying the ﬂoxed Alk5 allele (Alk5FXFX) with double heterozygote
Alk5KOWT/Tie2-Cre+/− and Alk5KOWT/Nkx2.5-Cre+/− mice, respectively
(Koni et al., 2001; Moses et al., 2001). First we veriﬁed that the Tie2-
Cre transgene is able to induce efﬁcient recombination of the ﬂoxed
Alk5 gene in the AV canal by using the RT-PCR analysis and primers
with target sequences ﬂanking the ﬂoxed exon 3 (Fig. 1A). The wild-
type sample demonstrated a single band of an expected size (399 bp),
while the mutant demonstrated a predominant ampliﬁcation product
of 156-bp representing a product of the recombined allele. This shows
that the Alk5 gene is predominantly expressed by endothelial cells,
and that the ﬂoxed allele of this gene is effectively recombined by
Tie2-Cre in vivo. While close to the expected 25% of mutant embryos
(Alk5/Tie2-Cre) were alive at E12 (n=10), they died soon after E13 with
severe hemorrhaging in several organs including the brain and
thoracic cavity (Fig 1B) (n=6). This is consistent with the endothelial
cell-speciﬁc expression of the Tie2-Cre transgene. In contrast, abroga-
tion of Alk5 in the entire myocardium using the well-characterized
Nkx2.5-Cre driver line (Moses et al., 2001) did not reveal any obvious
detectable cardiac phenotypes at E15 (Fig. 1C; n=3) or at E17 (data not
shown). This result is in concordance with ﬁndings reported in a
recent study demonstrating that cardiac development is not seriously
affected in mice lacking the Tgf-β type II receptor, a predominant
binding partner of Alk5, in the myocardium (Jiao et al., 2006).
Tgf-β signaling via Alk5 in the endocardium is required for normal
atrio-ventricular cushion development
Histological analysis of Alk5/Tie2-Cre mutant embryos at E10.0
indicated that the endocardial cushions in the AVC were grossly
hypoplastic, displaying a notable reduction in a number of cells in the
cushion mesenchyme (Figs. 2A–C). Although both superior and
inferior cushions were severely affected, the number of mesenchymal
cells in the inferior cushions was even more dramatically reduced at
E11.0 (Fig. 2C). Using the R26R lineage tracing assay at E11.0, we show
that although the endocardium in mutant samples stains strongly
positive for lacZ, there are very few, if any, positively staining cells iniently recombined in AVC tissues harvested at E10.0. RT-PCR using primers speciﬁc for
is deleted in Alk5/Tie2-Cremutants (a 156-bp PCR product), while the wild-type sample
thoracic bleeding (middle, black arrowheads) when compared to controls (left) at E12.
ow) indicative of a cardiac failure. High-power image has been shown in the inset. (C)
jor cardiac phenotypes in Alk5 mutants (right) when compared to controls (left). Two
V, ventricle; RA, right atrium; LA, left atrium; PT, pulmonary trunk; Ao, aorta.
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culture system to analyze whether endocardial cells lacking Alk5
would undergo EMT when cultured on 3-dimensional collagen gel
(Figs. 2F–H). While the control samples displayed a large number of
spindle-shaped cells penetrating the collagen gel, mutant cultures
failed to demonstrate similar migration. To conclude, these analyses
reveal that AVC explants harvested from Alk5/Tie2-Cre-deﬁcient
embryos failed to undergo EMT both in vitro and in vivo.
Defective myocardium in mice lacking Alk5 in the endocardium
Histological analysis of samples harvested at E12 revealed that the
myocardium was poorly trabeculated and much thinner in Alk5/Tie2-
Cre mutants than in controls (I–L). Moreover, the myocardium the
interventricular septum was poorly developed. At E12, the mutant
AVC cushions were still much smaller than controls, although they
occasionally displayed a slightly better formed mesenchyme indica-
tive of partial recovery (Fig. 2L). In contrast, the outﬂow tract cushionsFig. 2.Defective EMT, cushion development andmyocardium in Alk5/Tie2-Cremutants. While
mutant littermate shows no or very few mesenchymal cells (⁎) in AVC cushions (B). (C) Stati
(M) at E10 and E11. n=5, 5 sections per sample scored; SC, superior cushion; IC, inferior
mesenchymal cells in controls is derived from the endocardium at E11 (D, arrow), while the
origin (E, arrow). The AVC explants harvested from controls display a large number of ﬁbrobla
mutants there are no similar cells (⁎) detected (G). The histogram (H) depicts the statistical
samples (J, L) show the thinner myocardium and poor trabelucation when compared to con
ventricular septum; arrowhead in panel L depicts the ventricular septum). The Alk5/Tie
myocardium (hatched line in panels M and N) as demonstrated using BrdU incorporation assa
cells; red = MF20-positive myocardial cells). The histogram (O) illustrates quantiﬁcation of
sections per sample were scored; ⁎pb0.05).were rather well formed in Alk5/Tie2-Cre mutants (Fig. 2J). BrdU
incorporation and TUNEL assays demonstrated that the thin myocar-
dium in Alk5/Tie2-Cre mutants resulted from a defective myocardial
proliferation (Figs. 2M–O) rather than from increased apoptosis (data
not shown). Double staining for sarcomeric myosin heavy chain
(MF20) and BrdU indicated that more than 97% of the BrdU-positive
cells were of myocardial origin. It is noteworthy that the inappropri-
ately thin myocardium was not reported in Tgfbr2/Tie2-Cre mutants
(Jiao et al., 2006), which suggests that Alk5 mediates a broader
spectrum of signaling events than its prototypical binding partner,
Tgf-βRII in endocardial cells, as in neural crest cells (NCCs).
Alk5/Gata5-Cre mutants display ventral body wall and cardiac defects
To analyze the role of Alk5 in the epicardium, we opted to use the
Gata5-Cre transgenic mouse line that was recently shown to be an
efﬁcient inducer of Cre-mediated recombination in the PEO and in the
epicardium (Merki et al., 2005; Zamora et al., 2007). The Gata5-Crecontrol AVC cushions display a large number ofmesenchymal cells at E10 (A, arrow), the
stical comparison in a number of mesenchymal cells between controls (C) and mutants
cushion; ⁎pb0.05. The R26R lineage tracing analysis shows that a large number of
cushions of the mutant littermate displays only very few blue cells of endothelial cell
stoid-like cells (F, arrowheads) that migrate into the collagen gel, while in Alk5/Tie2-Cre
comparison between control and mutant cultures (⁎pb0.05; n=5). At E12, the mutant
trols (I, K; arrowheads depict the trabeculated myocardium; ⁎ in panel K illustrates the
2-Cre mutants demonstrate a clear attenuation in cell proliferation in the compact
y and comparison between control andmutant littermates (M, N; green = BrdU-positive
BrdU-positive cells in controls and in Alk5/Tie2-Cre mutants (n=5 in each genotype; 5
212 S. Sridurongrit et al. / Developmental Biology 322 (2008) 208–218transgene-induced recombination becomes detectable around E9.0 in
the ventral ectoderm and can be later seen in the developing liver and
also in the pulmonary epithelium (data not shown). We crossed the
Gata5-Cre mice (Merki et al., 2005) that were heterozygous for the
Alk5 knockout allele (Alk5+/−) with mice homozygous for the ﬂoxed
Alk5 (Alk5FX/FX) allele (Larsson et al., 2001). When the embryos were
harvested at E18, the expected 25% of mutant embryos could be
recovered (n=6). All the mutant embryos displayed a ventral body
wall closure defect, gastroschisis (Figs. 3A, B), as demonstrated by the
obvious extrusion of visceral organs through the ventral body wall.
However, the lungs and heart were normally positioned in the
thoracic cavity. A R26R lineage tracing assay at E14 demonstrated that
the heart was covered by lacZ-positive epicardial cells both in controls
and in Alk5 mutants suggesting that signaling via Alk5 is not needed
for the formation of the proepicardium, the migration of proepicardial
cells and the actual formation of the epicardium (Figs. 3C, D).
However, we noticed that in all of the mutant embryos analyzed
(n=5), the epicardiumwas inappropriately detached from the surface
of the myocardium (Fig. 3D). Moreover, in transverse histological
sections through the thorax at E13, both the compact and trabecular
myocardium of Alk5/Gata5-Cre mutants appeared thinner than those
of controls (Figs. 3E–H). While we did not detect any apoptotic
myocardial cells in mutants or in controls (data not shown), BrdUFig. 3. Alk5/Gata5-Cremutants display defects in the ventral bodywall, epicardiumandmyoca
A = control littermate. The epicardium of Alk5/Gata5-Cremutants (D) is abnormally loosely att
the normal epicardial morphology. The compact myocardial layer is abnormally thin in Alk5/G
Rectangular boxes in panels E and F depict the area shown in high power images in (panels G a
decrease in a number of BrdU-positive cells (green nuclei in panel J) when compared to cont
panels I, J). Statistical analyses of cell proliferation (K) show that at E11 there are no differenc
mutants (BrdU incorporation assay), while at E12 the number of proliferating cells in mutan
blue columns; mutants, red columns). At E12 the WT1-positive epicardial cell layer is abnor
white arrow)when compared to corresponding controls (L, white arrow). At E13 epicardial ce
(Q) when compared to corresponding control specimen (N, P). Arrows in panels L and N poiincorporation assay at E13 revealed that cell proliferation was
signiﬁcantly decreased in Alk5/Gata5-Cre mutants when compared
to controls (Figs. 3I–K). Immunostaining for the epicardial marker
WT1 demonstrated that the abnormally thin and poorly attached
epicardium is clearly noticeable already at E12 (Figs. 3L–M), while at
E11, we could not detect any differences between controls and
mutants (data not shown). A similar bubbling epicardium and thin
myocardium has also been described in mouse embryos lacking the
Ca2+-dependent cell adhesion molecule, N-cadherin, in neural crest
cells (Luo et al., 2006). Interestingly, these embryos also demonstrated
a notable downregulation of N-cadherin in epicardial cells. Since it is
likely that appropriate epicardial–myocardial cell–cell interactions
play an important role in generation of proper proliferative signals
from the epicardium, and that cell adhesion molecules play a major
role in maintenance of these interactions, we compared N-cadherin
and the tight junction protein, ZO1 between controls and Alk5/
Gata5-Cre mutants. Our experiment shows that N-cadherin was
down-regulated in the epicardium of Alk5/Gata5-Cre mutants (Fig.
3O) when compared to that of controls (Fig. 3N). Moreover, the control
epicardium stained strongly positive for ZO1, not only in cell–cell
junctions, but interestingly also in the basal surface and also in the
subepicardial space, whereas mutants displayed decreased staining
(Figs. 3P–Q). To conclude, our results demonstrate that while Alk5-rdium. Ventral bodywall fails to fuse inAlk5/Gata5-Cremutants (arrow inpanel B) at E18;
ached to themyocardium (blue staining cells; R26R assay). The control (C) demonstrates
ata-Cremutants (F, H), while controls (E, G) display a normal compact myocardial layer.
nd H). At E12, the compact myocardium (hatched line) of Alk5/Gata5-Cremutants shows
rols (I). Immunostaining for MF20 was used to identify myocardial cells (red staining in
es in cell proliferation in the compact myocardium between controls and Alk5/Gata5-Cre
ts is signiﬁcantly decreased (⁎pb0.05) in mutants when compared to controls (controls,
mally thin in Alk5/Gata5-Cre mutants and appears detached from the myocardium (M,
lls of Alk5/Gata5-Cremutants display an attenuated expression ofN-cadherin (O) and ZO1
nt to a positive signal in controls, and to reduced (M) or absent (O) signal in mutants.
Fig. 4. Epicardial EMT fails in Alk5/Gata5-Cre mutants in vitro. Control and Alk5/Gata5-Cre epicardial cell cultures were established from E12 embryos and stimulated with Tgf-β3
(10 ng/ml) for 24 h. Unstimulated cultures [both control (A) and mutant (B)] displayed positive ZO1 (red) and FITC-phalloidin (green) staining in cell–cell junctions consistent with an
epithelial phenotype. Control cultures stimulated with Tgf-β3 showed a noticeable loss of ZO1 from cell–cell borders and a robust formation of actin stress ﬁbers (C), while mutant
cultures failed to display comparable phenotypic changes (D).
213S. Sridurongrit et al. / Developmental Biology 322 (2008) 208–218mediated signaling is not needed for epicardial formation per se, it is
likely required for appropriate epicardial attachment, which in turn is
a prerequisite for appropriate myocardial proliferation.
Alk5 deﬁcient epicardial cells fail to undergo EMT when stimulated by
Tgf-β in vitro
Next we established epicardial cultures from control and Alk5/
Gata5-Cre embryos at E12 (Chen et al., 2002), and after 24 h in culture,
stimulated them with 10 ng/ml of hrTgf-β3 (Fig. 4). Both control and
Alk5/Gata5-Cre mutant epicardial cells (without Tgf-β stimulation)
stained strongly positive for the tight junction marker ZO1 (red) and
displayed f-actin (green) predominantly in cell–cell junctions (Hordijk
et al.,1997) (Figs. 4A, B). Control cultures treatedwith Tgf-β3 displayed
a pronounced loss of ZO1 from tight junctions, and an obvious
formation of stress ﬁbers typically seen in ﬁbroblastoid cells (Fig. 4C).
In contrast to controls, cells lacking Alk5 did not show detectable
changes in reorganization of actin cytoskeleton or in dissolution of
tight junctions after Tgf-β3 treatment (Fig. 4D). These analyses
demonstrate that signaling via Alk5 is required for successful
epicardial transformation in vitro.
Myocardial vascularization in Alk5/Gata5-Cre mutants
To analyze whether the lack of Alk5-mediated signaling in the
epicardium would lead to defective coronary vessel development, we
stained both the control and Alk5/Gata5-Cre mutant hearts for the
endothelial cell marker PECAM-1 at E13 and E15. Both controls and
Alk5/Gata5-Cre mutants formed a similar vascular subepicardial
network (Figs. 5A, C). Similarly, analysis of freshly dissected mutant
embryos at E18.0 did not reveal any obvious macroscopic coronary
vessel abnormalities (Figs. 5B, D). Serial sectioning from rostral to
caudal demonstrated that both the right and left coronary ostia and
coronary arteries are histologically comparable between controls and
mutants at E17 (Figs. 5E–L, and data not shown). However, mutant
coronary arteries demonstrated much weaker staining for vascular
smooth muscle myosin suggesting defective development of smooth
muscle cell layer surrounding the coronary arteries (Figs. 5M, N).
Moreover, a histological analysis at E18 revealed that the myocardiumappeared to containmore small blood-ﬁlled vessels inmutants than in
controls (Figs. 6A, B).
To compare myocardial vascularization in more detail, we
performed immunostaining for PECAM-1 (endothelial marker),
Claudin-5 (a tight junction marker for vascular endothelial cells),
ZO-1 (a tight junction marker) and VE-cadherin (marker for vascular
endothelial cells) at E17 and E18. In controls, all these endothelial/
epithelial markers stained the endothelial lining of the coronary
vessels strongly, while the staining was relatively weak in other parts
of the myocardium Figs. 6C, E, G, I). In contrast, the number of
positively staining cells was notably high in the myocardium of Alk5/
Gata5-Cre mutants (Figs. 6D, F, H, J). Moreover, epicardial cells in
controls stained strongly positive for VE-cadherin, while the mutant
epicardial cells did not demonstrate any noticeable staining
(Figs. 6I, J). Similar differences in the number of VE-cadherin, ZO1
and Claudin-5 positive cells were not detectable at E13. Thus, the
increased number of smaller myocardial vessels can be explained by
the abnormal remodeling and/or proliferation of subepicardial
vasculature in embryos lacking Alk5-mediated Tgf-β signaling. Since
epicardial Fgf-signaling has been implicated in the control of vascular
proliferation during cardiac development and regeneration, we
analyzed expression of several Fgfs in the ventricles using semi-
quantitative PCR at E16.0. As can be seen in Fig. 6K, Fgfs1, -7 and -10
were expressed on equal levels in controls and mutants. Interestingly,
Fgf9 was clearly upregulated in mutants when compared to controls
(Figs. 6K, L).
Discussion
Alk5 and Tgf-β signaling in the myo- and endocardium
An important role of EMT during AVC development is well
established (Markwald et al., 1981; Runyan and Markwald, 1983).
Moreover, several key studies have demonstrated an instrumental role
of Tgf-β superfamily signaling in induction of EMT in the chick (Potts
et al., 1991; Potts and Runyan, 1989). However, the mechanism of EMT
in mammals is still poorly understood. None of the Tgf-β mouse
knockouts display any obvious defects that could be causally related to
a failure in endocardial EMT(Kaartinen et al., 1995; Proetzel et al.,
Fig. 5. Coronary vessels develop, but fail to demonstrate appropriate smooth muscle cell differentiation in Alk5/Gata5-Cre mutants. PECAM-1 whole mount staining reveals a
comparable vascular plexus between controls (A) and mutants (C) at E15. Freshly mounted hearts at E18 show no differences between coronary arteries (arrows in panels B and D) in
control (B, dorsal view) and Alk5/Gata5-Cre (D, dorsal view) embryos. Serial sectioning (rostral to caudal) shows no obvious abnormalities in the coronary ostia (E, G, arrows) and
coronary arteries (F, H, I–L, arrows) in mutants (G, H, K, L) when compared to controls (E, F, I, J). Immunostaining for vascular smooth muscle myosin demonstrates a well-formed
smooth muscle cell layer surrounding the coronary arteries in controls (M), but not in Alk5/Gata5-Cre mutants (N). Ao, aorta; LCA, left coronary artery; RCA, right coronary artery.
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reported that the Tgf-β type II receptor is not required in endothelial
cells for normal EMT in vivo (Jiao et al., 2006). In fact, the recent data
contend that Bmps rather than Tgf-βs would likely play more
important roles (summarized in Fig. 7); ﬁrst, it has been shown that
Bmp2 is needed for induction of EMT in mice and second, Bmp type I
receptors Alk2 and Alk3 are required in endothelial cells for successful
EMT in vivo(Ma et al., 2005; Park et al., 2006; Rivera-Feliciano and
Tabin, 2006; Song et al., 2007; Sugi et al., 2004; Wang et al., 2005). On
the other hand, we have shown before that in Alk2/Tie2-Cre mutants,
phosphorylation of both Bmp and Tgf-β Smads is attenuated in the
endocardium implicating a possible cross-talk between Tgf-β and
Bmp signaling in endocardial transformation (blue hatched arrow in
Fig. 7).
In the present study we show that the Tgf-β type I receptor Alk5 is
required for normal EMT in mice. This ﬁnding is consistent with a
recent report from the Runyan laboratory, which demonstrated that
Alk5 is required for AVC EMT in chick embryos (Mercado-Pimentel
et al., 2007). However, our present results also raise an interesting
question about the nature of Tgf-β signals mediated via Alk5, since asreported by Jiao et al., Tgf-βRII is not involved with AVC EMT in vivo
(Jiao et al., 2006). It is possible that ligands other than prototypic Tgf-
βs are involved, or alternatively, maybe other Type-II receptors can
substitute for the loss of Tgfbr2. Additional evidence implicating the
unconventional partnership of Alk5with other type II receptors comes
from the myocardial defects found in Alk5/Tie2-Cre but not inTgfbr2/
Tie2-Cre embryos (Jiao et al., 2006). This ﬁnding suggests that Alk5
signaling in the endocardium is important for the expression of
mitogens essential for myocardial proliferation and survival of the
trabeculated myocardium. Several knockout studies have shown that
Bmps 6, -7, and -10 are necessary for the trabeculation (Chen et al.,
2004; Kim et al., 2001). Therefore, it is possible the levels of these
Bmps are reduced in the endocardium of the Alk5/Tie2-Cre embryos,
or that defects seen in Alk5/Tie2-Cre mutants are due to inefﬁcient
Bmp response in endocardial cells. These Bmp signals are probably
mediated by Alk3 but not by Alk2, since myocardial deletion of Alk3
(Gaussin et al., 2002), but not that of Alk2 (Wang et al., 2005) results in
abnormal trabeculation. However, Tie2-Cre recombines not only in
endocardial cells but also in other endothelial cells including the ones
in coronary arteries. Therefore, we cannot exclude a possibility that
Fig. 6. Abnormal myocardial capillary vasculature in Alk5/Gata5-Cre mutants. Alk5/Gata-Cre mutants (B) display a higher number of myocardial blood vessels (arrows) than control
littermates (A) as demonstrated by H&E staining at E17. Immunostaining for PECAM-1 (C, D), Claudin-5 (E, F), ZO1 (G, H) and VE-cadherin (I, J) showmore intensemyocardial staining
in Alk5/Gata5-Cre mutants (arrows in panels D, F, H and J) than in controls (C, E, G and I). Samples for PECAM-1 staining were collected at E18, while samples for all other stainings
were harvested at E17. However, the epicardium inmutants (arrow in panel J) did not stain for VE-cadherin, while in controls the epicardium (arrow in panel I) demonstrated a strong
positive staining. (K) RT-PCR analysis demonstrates that at E16 Fgf9 is increased in Alk5/Gata5-Cremutants (M1 and M2) when compared to controls (C1 and C2), while Fgf1, Fgf7 and
Fgf10 are unchanged. C1 and C2, and M1 and M2 represent two independent control and mutant samples, respectively. Two-fold increase in Fgf9 expression was conﬁrmed by real-
time PCR analysis (L) (Control, blue column; Mutant, red column; n=3).
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myocardium, maybe caused be a more generic failure in the vascular
system.
Our ﬁnding that Alk5 mediated Tgf-β signaling may not be critical
for development of the myocardium is concordant with ﬁndings of a
recent study demonstrating that Tgf-β type II receptor in the
myocardium is dispensable for cardiogenesis (Jiao et al., 2006).
Collectively these studies argue that unlike Bmp receptor signaling
(Gaussin et al., 2002), the corresponding Tgf-β signaling is not
required cell autonomously in myocardial cells for cardiac growth
and development.
Alk5 in epicardial cells
Several recent studies have emphasized a role of the epicardium in
cardiac development, particularly in regulation of myocardial growth
and function, as well as in generation of coronary arteries (Chen et al.,
2002; Lavine and Ornitz, 2008). This is of signiﬁcant interest, since
understanding of mechanisms by which the epicardium regulates these
processes during embryogenesis could result in strategies designed to
effectively treat myocardial damage following the ischemic injury later
in life. In this study, we show that Tgf-β signaling via Alk5 is critically
important for appropriate function of the epicardium during cardiac
development. In Alk5/Gata5-Cremutants, there is inappropriate attach-
ment of the epicardium to the myocardial layer. Moreover, the
expression of the cell adhesion molecules N-cadherin, and VE-cadherinis down-regulated in mutant samples. Interestingly, a similar pheno-
type, i.e., the detached epicardium and thin myocardium, has been
recently reported inneural crest-speciﬁcN-cadherinmutantmice. These
mice also display decreased expression of N-cadherin in the epicardium
(Luo et al., 2006). Therefore, it is conceivable that Tgf-β-mediated
signaling via Alk5 regulates expression of genes of cell adhesion
molecules, e.g., cadherins, which in turn are needed for appropriate
interactions between epicardial and myocardial cells to regulate
myocardial proliferation. Alternatively, it is possible that inappropriate
attachment of epicardial cells prevents the function of epicardium-
speciﬁc mitogenic growth factors, which could lead to an attenuated
myocardial proliferation seen in Alk5/Gata5-Cremutants.
It has been suggested that the epicardium functions as a signaling
center for mid-gestational cardiac development (Lavine and Ornitz,
2008). One subgroup of these critical signals is Fgfs, which have been
shown to play key roles in coronary vessel development in the
mouse (Lavine and Ornitz, 2008). In the chick, both Fgfs and Bmps
were reported to promote epicardial EMT, with Tgf-βs opposing the
Fgf-induced epicardial EMT (Morabito et al., 2001). However, other
studies have disputed these ﬁndings and suggest that in avians Tgf-
βs will potently induce epicardial EMT (Compton et al., 2006; Dokic
and Dettman, 2006). The importance of Tgf-β signaling in coronary
vessel development was recently further emphasized by the ﬁndings
of the Barnett group showing that coronary arteries fail to develop in
mouse embryos lacking the functional gene encoding the Tgf-β type
III receptor (Tgfbr3) (Compton et al., 2007). Our present in vivo study
Fig. 7. Amodel illustrating Tgf-β superfamily signaling in endocardial EMT [selected ﬁndings of recent studies with relevance to Tgf-β superfamily signaling in endocardial EMT have
been summarized]. Bmp2 (and possibly also other Bmps) secreted from the AVC myocardium binds to the Bmp and activin type II receptors, which in turn activate type I receptors
Alk3 and Alk2 (Desgrosellier et al., 2005; Lai et al., 2000; Ma et al., 2005; Rivera-Feliciano and Tabin, 2006; Song et al., 2007; Sugi et al., 2004;Wang et al., 2005). Similarly, other Tgf-β
superfamily ligands secreted from the myocardium bind to type II receptors, which consecutively leads to activation of Alk5 that is required for endocardial EMT both in the chick
(Mercado-Pimentel et al., 2007) and in the mouse (present study). While a recent study showed that Tgf-β type II receptor (TgfβRII) does not play any non-redundant roles in
endocardial transformation in vivo (Jiao et al., 2006), the Tgf-β type III receptor was recently shown to play an important role in enhancing binding of Bmp2 to its receptors (Kirkbride
et al., 2008). Whether this signaling (red hatched arrow) is dependent on Alk5 activity remains to be seen. Alk2- and Alk3 signaling mediated via Bmp Smads, particularly Smad1,
leads to the increased expression of several target genes. Some of these events are likely pathway speciﬁc (Ma et al., 2005). Moreover, it has been suggested that activation of Tgf-β
Smads in endocardial cells is dependent on Alk2 (blue hatched arrow), but not on Alk3 activity(Ma et al., 2005;Wang et al., 2005). In a parallel canonical Tgf-β pathway, activated Alk5
signaling via Tgf-β Smads leads to activation of several known target genes (Mercado-Pimentel et al., 2007). Simultaneously, phosphorylation of Par6c with the type II receptor–Alk5
complex leads to a rapid degradation of RhoA, which is necessary for dissolution of tight junctions during EMT (Townsend et al., 2008; Wang et al., 2003).
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signaling via Alk5 in epicardial cells is needed for epicardial to
mesenchymal transformation in epicardial cultures, it is not required
for coronary artery formation. This is clearly highlighted by the fact
that the mutant embryos survive until birth, indicating that coronary
vasculature is sufﬁciently well developed to support adequate
cardiac function. Instead, we observed that Alk5/Gata5-Cre mutants
display a defective smooth muscle cell layer surrounding coronaryarteries as demonstrated by immunostaining for vascular smooth
muscle myosin. Tgf-β signaling can induce smooth muscle cell
differentiation of multi-potent NCCs in vitro(Shah et al., 1996);
however, the in vivo role of Tgf-βs in this process is controversial
(Choudhary et al., 2006). Our present ﬁndings suggest that Tgf-β
signaling through Alk5 is required for normal differentiation of
epicardium-derived progenitor cells to a smooth muscle layer
surrounding the coronary arteries.
217S. Sridurongrit et al. / Developmental Biology 322 (2008) 208–218The Alk5/Gata5-Cre mutant embryos also display a pronounced
increase in the microvasculature in the myocardium when compared
to controls. Recent studies have shown that in the adult zebraﬁsh,
which has a unique capacity for cardiac regeneration, the epicardium
plays a critical role in generation of a fostering vascularized niche that
can promote and support other aspects of regenerative cardiogenesis
(Lepilina et al., 2006). Epicardially-derived Fgfs have been suggested
to play a key role in development of myocardial vascularization, both
during mouse cardiac development as well as during zebraﬁsh cardiac
regeneration (Lavine and Ornitz, 2008; Lepilina et al., 2006).
Interestingly, our present studies suggest that Tgf-β signaling via
Alk5 functions upstream of Fgfs during late cardiac development
(E16–E18). In contrast, other studies have demonstrated that the
epicardium-derived Fgf9 is a key mitogen in the myocardial
proliferation (Lavine and Ornitz, 2008). However, it is likely that
Alk5 signaling in regulation of Fgf9 expression is restricted to late
gestation, since we could detect the congested myocardial capillaries
only after E16.
To conclude, we demonstrate that signaling via Alk5 is required for
normal EMT in the endocardium (see also Fig. 7), and that Alk5
mediated signaling is required for normal epicardial–myocardial cell–
cell interactions and for subsequent proliferation of the myocardium.
Moreover, our present results imply that while Alk5-mediated
signaling is not required for coronary vessel development per se, it
plays a role in development of smooth muscle cell layer surrounding
coronary arteries and controlling homeostasis of the myocardial
vascular plexus.
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